Pegvisomant in Combination With Long-Acting Somatostatin Analogues in Acromegaly: The Role of the GH Receptor Deletion of Exon 3
European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-15-0519
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Bioscientifica